Danaher Corporation

NYSE

Market Cap.

171.63B

Avg. Volume

3.09M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Danaher Corporation

Danaher Corporation News

Danaher Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareMedical - Diagnostics & Research
danaher.com

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Danaher Corporation Earnings & Revenue

Danaher Corporation Financials

Table Compare

Compare DHR metrics with:

   

Earnings & Growth

DHR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DHR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DHR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DHR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Danaher Corporation Income

Danaher Corporation Balance Sheet

Danaher Corporation Cash Flow

Danaher Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Danaher Corporation Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.0800

Payment DateDividendFrequency
2025-01-310.27Quarterly
2024-10-250.27Quarterly
2024-07-260.27Quarterly
2024-04-260.27Quarterly
2024-01-260.24Quarterly

Danaher Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Historical Market Cap

Shares Outstanding

Danaher Corporation Executives

NameRole
Mr. Rainer M. BlairPresident, Chief Executive Officer & Director
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice President
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer
Mr. Brian W. Ellis J.D.Senior Vice President, General Counsel & Chief Compliance Officer
Ms. Georgeann F. CoucharaSenior Vice President of Human Resources
NameRoleGenderDate of BirthPay
Mr. Rainer M. BlairPresident, Chief Executive Officer & DirectorMale19645.33M
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice PresidentMale19722.56M
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer19622.09M
Mr. Brian W. Ellis J.D.Senior Vice President, General Counsel & Chief Compliance OfficerMale19671.93M
Ms. Georgeann F. CoucharaSenior Vice President of Human ResourcesFemale19771.66M

Danaher Corporation Insider Trades

Date27 May
NameFILLER LINDA
RoleDirector
TransactionDisposed
TypeG-Gift
Shares21590
Date25 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionDisposed
TypeS-Sale
Shares8370
Date26 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionAcquired
TypeM-Exempt
Shares26318
Date26 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionDisposed
TypeS-Sale
Shares26318
Date26 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionDisposed
TypeM-Exempt
Shares26318
DateNameRoleTransactionTypeShares
27 MayFILLER LINDADirectorDisposedG-Gift21590
25 NovRaskas DanielSVP - Corporate DevelopmentDisposedS-Sale8370
26 NovRaskas DanielSVP - Corporate DevelopmentAcquiredM-Exempt26318
26 NovRaskas DanielSVP - Corporate DevelopmentDisposedS-Sale26318
26 NovRaskas DanielSVP - Corporate DevelopmentDisposedM-Exempt26318

Discover More

Streamlined Academy

Danaher Corporation

NYSE

Market Cap.

171.63B

Avg. Volume

3.09M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Danaher Corporation News

Danaher Corporation Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Danaher Corporation Earnings & Revenue

Danaher Corporation Income

Danaher Corporation Balance Sheet

Danaher Corporation Cash Flow

Danaher Corporation Financials Over Time

Danaher Corporation Executives

NameRole
Mr. Rainer M. BlairPresident, Chief Executive Officer & Director
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice President
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer
Mr. Brian W. Ellis J.D.Senior Vice President, General Counsel & Chief Compliance Officer
Ms. Georgeann F. CoucharaSenior Vice President of Human Resources
NameRoleGenderDate of BirthPay
Mr. Rainer M. BlairPresident, Chief Executive Officer & DirectorMale19645.33M
Mr. Matthew R. McGrewChief Financial Officer & Executive Vice PresidentMale19722.56M
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Senior Vice President & Chief Science Officer19622.09M
Mr. Brian W. Ellis J.D.Senior Vice President, General Counsel & Chief Compliance OfficerMale19671.93M
Ms. Georgeann F. CoucharaSenior Vice President of Human ResourcesFemale19771.66M

Danaher Corporation Insider Trades

Date27 May
NameFILLER LINDA
RoleDirector
TransactionDisposed
TypeG-Gift
Shares21590
Date25 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionDisposed
TypeS-Sale
Shares8370
Date26 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionAcquired
TypeM-Exempt
Shares26318
Date26 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionDisposed
TypeS-Sale
Shares26318
Date26 Nov
NameRaskas Daniel
RoleSVP - Corporate Development
TransactionDisposed
TypeM-Exempt
Shares26318
DateNameRoleTransactionTypeShares
27 MayFILLER LINDADirectorDisposedG-Gift21590
25 NovRaskas DanielSVP - Corporate DevelopmentDisposedS-Sale8370
26 NovRaskas DanielSVP - Corporate DevelopmentAcquiredM-Exempt26318
26 NovRaskas DanielSVP - Corporate DevelopmentDisposedS-Sale26318
26 NovRaskas DanielSVP - Corporate DevelopmentDisposedM-Exempt26318

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
danaher.com

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Danaher Corporation

Danaher Corporation Financials

Table Compare

Compare DHR metrics with:

   

Earnings & Growth

DHR

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

DHR

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

DHR

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

DHR

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Danaher Corporation Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.0800

Payment DateDividendFrequency
2025-01-310.27Quarterly
2024-10-250.27Quarterly
2024-07-260.27Quarterly
2024-04-260.27Quarterly
2024-01-260.24Quarterly

Danaher Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioSell
Price/Earnings RatioStrong Sell
Price/Book RatioSell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

A Practical Guide: How To Analyze Any Stock (With Examples)